TRIV-920

N/A

Report date: 2024/10/15 17:27:19

Base Information

Drug NameTRIV-920

Drug Alias NameTRIV-920

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTrypsin inhibitors

TargetsTrypsin

Therapy Area/IndicationsPancreatitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTriveni Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesTriveni Bio Inc

Inactive CompaniesN/A

Active IndicationsPancreatitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A